Increlex: the only FDA-approved treatment used for severe Primary IGFD, a growth disorder

Get Increlex (mecasermin [rDNA origin] injection) information here at the official. Efficacy, side effect, and prescribing information provided here. Your child should not take INCRELEX if your child: has finished growing (the growth plates at the end of the bones are closed); has cancer; has other causes of growth failure; OR is allergic to mecasermin or any of the inactive ingredients in INCRELEX. INCRELEX has not been studied in children under 2 years of age and should never be used in newborns.